Paxlovid

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Oct 18, 2023
Approval ID: 8a99d6d6-fd9e-45bb-b1bf-48c7f761232a
Products: 5 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PAXLOVID safely and effectively. See full prescribing information for PAXLOVID. PAXLOVID (nirmatrelvir tablets; ritonavir tablets), co-packaged for oral use Initial U.S. Approval: 2023

Quick Stats

Total Products5

Labelers2

Label Sections47

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.